drugset / Trial / NCT04032964
Dose Finding Study of L19TNF and Doxorubicin in Patients With STS
NaSequentialOpen-labelTreatment
Summary
The study is aimed at evaluating the safety of L19TNF in combination with the most appropriate dose of doxorubicin.
Timeline
- Start
- 2019-09-05
- Primary completion
- 2024-12
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 75 mg/m2 | Intravenous |
| Subject | Onfekafusp alfa | Protein / enzyme biologic | 13 ug/kg | Intravenous |